ATE260281T1 - Diazacyclooctanverbindungen und ihre therapeutische verwendung - Google Patents

Diazacyclooctanverbindungen und ihre therapeutische verwendung

Info

Publication number: ATE260281T1
Authority: AT; Austria
Prior art keywords: alkyl; chem; formula; aryl; heteroaryl
Prior art date: 2000-08-03

Application number

AT01306313T

Other languages

English (en)

Inventor

Anton Franz Josef Fliri

Randall James Gallaschun

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-03

Filing date

2001-07-23

Publication date

2004-03-15

2001-07-23 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-03-15 Application granted granted Critical

2004-03-15 Publication of ATE260281T1 publication Critical patent/ATE260281T1/de

Links

KJGHYQZXEYTDSW-UHFFFAOYSA-N diazocane Chemical class C1CCCNNCC1 KJGHYQZXEYTDSW-UHFFFAOYSA-N 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 10
125000003118 aryl group Chemical group 0.000 abstract 2
229910052794 bromium Inorganic materials 0.000 abstract 2
229910052801 chlorine Inorganic materials 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
125000001072 heteroaryl group Chemical group 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 abstract 1
NFDXQGNDWIPXQL-UHFFFAOYSA-N 1-cyclooctyldiazocane Chemical class C1CCCCCCC1N1NCCCCCC1 NFDXQGNDWIPXQL-UHFFFAOYSA-N 0.000 abstract 1
125000002837 carbocyclic group Chemical group 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
229910052731 fluorine Inorganic materials 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
229910052740 iodine Inorganic materials 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT01306313T 2000-08-03 2001-07-23 Diazacyclooctanverbindungen und ihre therapeutische verwendung ATE260281T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US22270600P	2000-08-03	2000-08-03

Publications (1)

Publication Number	Publication Date
ATE260281T1 true ATE260281T1 (de)	2004-03-15

Family

ID=22833344

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01306313T ATE260281T1 (de)	2000-08-03	2001-07-23	Diazacyclooctanverbindungen und ihre therapeutische verwendung

Country Status (12)

Country	Link
US (1)	US6531468B2 (de)
EP (1)	EP1178047B1 (de)
JP (1)	JP3825657B2 (de)
AT (1)	ATE260281T1 (de)
BR (1)	BR0103180A (de)
CA (1)	CA2354605C (de)
DE (1)	DE60102106T2 (de)
DK (1)	DK1178047T3 (de)
ES (1)	ES2211738T3 (de)
MX (1)	MXPA01007955A (de)
PT (1)	PT1178047E (de)
TR (1)	TR200400510T4 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060270847A1 (en) *	2003-06-27	2006-11-30	Seiji Morii	Process for producing nitrogenous heterocyclic compound
US7704991B2 (en)	2005-04-04	2010-04-27	Neurosearch A/S	Substituted diazabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
BRPI0908807A2 (pt)	2008-02-15	2015-07-28	Hoffmann La Roche	Derivados de 3-alquil-piperazina e usos dos mesmos
EP2305653B9 (de)	2008-07-23	2015-06-24	Toray Industries, Inc.	Therapeutikum für chronisches nierenversagen
KR20250107951A (ko)	2009-06-26	2025-07-14	니뽄 신야쿠 가부시키가이샤	결정
IN2015MN00002A (de)	2012-07-09	2015-10-16	Lupin Ltd
US10231970B2 (en)	2014-09-30	2019-03-19	NV Heterocycles	Methods of producing heteropolycycles via bis-epoxidation
SI4331607T1 (sl)	2015-12-02	2025-06-30	Nippon Shinyaku Co., Ltd.	Trdni farmacevtski sestavek, ki vsebuje 2-{4-[n-(5,6-difenilpirazin-2-il)-n-izopropilamino]butiloksi}-n-(metilsulfonil)acetamid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3951980A (en) *	1974-05-09	1976-04-20	Stanford Research Institute	3-Substituted-8-methyl-3,8-diazabicyclo[3.2.1]octanes
FR2531709A1 (fr) *	1982-08-13	1984-02-17	Sanofi Sa	Diazabicyclooctanes, procede pour leur preparation et compositions pharmaceutiques les renfermant

2001
- 2001-07-23 DE DE60102106T patent/DE60102106T2/de not_active Expired - Fee Related
- 2001-07-23 PT PT01306313T patent/PT1178047E/pt unknown
- 2001-07-23 DK DK01306313T patent/DK1178047T3/da active
- 2001-07-23 ES ES01306313T patent/ES2211738T3/es not_active Expired - Lifetime
- 2001-07-23 AT AT01306313T patent/ATE260281T1/de not_active IP Right Cessation
- 2001-07-23 TR TR2004/00510T patent/TR200400510T4/xx unknown
- 2001-07-23 EP EP01306313A patent/EP1178047B1/de not_active Expired - Lifetime
- 2001-08-01 CA CA002354605A patent/CA2354605C/en not_active Expired - Fee Related
- 2001-08-01 BR BR0103180-5A patent/BR0103180A/pt not_active IP Right Cessation
- 2001-08-01 US US09/920,587 patent/US6531468B2/en not_active Expired - Fee Related
- 2001-08-02 JP JP2001235227A patent/JP3825657B2/ja not_active Expired - Fee Related
- 2001-08-03 MX MXPA01007955A patent/MXPA01007955A/es unknown

Also Published As

Publication number	Publication date
US20020068748A1 (en)	2002-06-06
BR0103180A (pt)	2002-03-26
MXPA01007955A (es)	2002-08-06
EP1178047B1 (de)	2004-02-25
DK1178047T3 (da)	2004-05-24
PT1178047E (pt)	2004-05-31
US6531468B2 (en)	2003-03-11
EP1178047A1 (de)	2002-02-06
JP3825657B2 (ja)	2006-09-27
CA2354605C (en)	2006-05-30
DE60102106T2 (de)	2004-07-15
CA2354605A1 (en)	2002-02-03
JP2002088084A (ja)	2002-03-27
ES2211738T3 (es)	2004-07-16
TR200400510T4 (tr)	2004-08-23
DE60102106D1 (de)	2004-04-01

Legal Events

Date

Code

Title

Description

2004-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1178047

Country of ref document: EP

2008-04-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
IS2293B (is)	2007-10-15	Arýl sambrædd asapólýsýklísk efnasambönd
DE69332754D1 (de)	2003-04-17	Anregende Aminosäuren Antagonisten
ATE139233T1 (de)	1996-06-15	Annelierte thiophen-derivate, ihre herstellung und verwendung
ATE252576T1 (de)	2003-11-15	Heteroarylphenylpyrazolverbindungen zur verwendung als analgetisches/entzündungshemmendes mittel
DE60111464D1 (de)	2005-07-21	Azabicycloalkan-Derivate zur Verwendung als Inhibitoren der Serotonin-Wiederaufnahme und als 5HT2a Antagonisten
ATE260281T1 (de)	2004-03-15	Diazacyclooctanverbindungen und ihre therapeutische verwendung
HUT57773A (en)	1991-12-30	Process for produicng n-(aminocarbonyl)-carbamates related to physostigmine, as well as pharmaceutical compositions comprising such compounds
BR0011127A (pt)	2002-02-19	Derivados de 4-fenil-pirimidina
BR0205683A (pt)	2004-07-06	Processo para a preparação de derivados de piperazina, e, mesilato de um composto
JP2005538965A (ja)	2005-12-22	関節炎を治療するためのｍｍｐ−１３阻害剤としてのチアジン及びオキサジン誘導体
PT1083178E (pt)	2004-12-31	Tetra-hidroquinazolino-2, 4-dionas e suas utilizacoes terapeuticas
HUT63159A (en)	1993-07-28	Process for producing tokoferol derivatives and pharmaceutical compositions comprising same as active ingredient
ATE388945T1 (de)	2008-03-15	Benzoxazolderivate und deren verwendung als adenosinrezeptorliganden
NO20033049D0 (no)	2003-07-03	Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1
DE69110219D1 (de)	1995-07-13	3-(1H-Indazol-3-yl)-4-pyridiname, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
NO20020475D0 (no)	2002-01-29	2-aminotetralinderivater for terapi av glaukom
ATE258934T1 (de)	2004-02-15	Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
ATE186912T1 (de)	1999-12-15	Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
ATE241985T1 (de)	2003-06-15	Therapeutisches mittel zur behandlung von nierenerkrankungen